Patients with myasthenia gravis (MG) largely expressed negative emotions around MG treatment and symptom burden in patient focus groups and on MG social media discussion boards.

Global health | Image Credit: © zephyr_p - stock.adobe.com

Worldwide Incidence, Prevalence of MG Has More Than Doubled Since 1950s

By AJMC Contributor

November 14th 2024

The data come from a systematic review of over 90 studies between 1952 through 2022, which found that both prevalence and incidence rates have than doubled throughout the study period.

AI graphic | Image Credit: © NicoElNino-stock.adobe.com

Enhancing Myasthenia Gravis Care With AI-Powered Telemedicine

By Kimberly Rath, PharmD

November 8th 2024

Researchers introduce a telemedicine system powered by artificial intelligence (AI) that automatically scores neuromuscular examinations, offering the potential to enhance patient monitoring, reduce variability in clinical trials, and improve access to care for neuromuscular disorders like myasthenia gravis.

Myasthenia gravis | Image Credit: © lexiconimages-stock.adobe.com

COVID-19 Exacerbations in Myasthenia Gravis Linked to Severity

By Kimberly Rath, PharmD

November 5th 2024

This new study investigated the impact of COVID-19 on patients with myasthenia gravis, finding that although most patients did not experience severe COVID-19, a significant portion suffered postinfection exacerbations.

MG notes concept | image credit: Andrii - stock.adobe.com

Rozanolixizumab Effective in Patients With MuSK MG, Analysis Shows

By Jared Kaltwasser

October 23rd 2024

A new subgroup analysis of patients with muscle-specific tyrosine kinase (MuSK) autoantibody-positive (Ab+) myasthenia gravis (MG) shows rozanolixizumab (Rystiggo) contributes to meaningful symptom improvement.

<1 2 3 4 5

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions